Get Sevin Rosen Funds contact and information in the United States

Investor Type	Firm
Type of Fund	Venture Capital Fund
Industries	Software (Web Marketplace Saas..) • IT (& TMT) • Media • BioTech • Businesses Solutions • FinTech (& Financials services) • Hardware (& Manufacturing) • Energy • A.I. (& Big Data) • HealthTech (& Fitness) • Gaming (& eSports) • Food & Beverage • Logistics (& Distribution) • Material Science • Medical Devices (& Hospital Services) • SaaS • Life Science • Nanotechnology • Oncology • Oil & Gas (& Mining) • Semiconductors • Productivity
Stages	Seed, Series A, Series B
Investing	United States • Germany • India
Investment Range	$44,380,000 - $44,380,000

Who are the key investors at Sevin Rosen Funds?

What is Sevin Rosen Funds?

Sevin Rosen Funds is a venture capital firm with a history dating back to 1981. Based in Dallas, Texas, they are known for investing in startups across a diverse array of industries.

Their investment reach extends to sectors such as Software, inclusive of web marketplaces and SaaS (Software as a Service); Information Technology and TMT (Technology, Media, and Telecom); Media; BioTech; Business Solutions; FinTech and Financial Services; Hardware and Manufacturing; Energy; A.I. and Big Data; HealthTech and Fitness; Gaming and eSports; Food and Beverage; Logistics and Distribution; Material Science; Medical Devices and Hospital Services; Life Science; Oncology; Oil & Gas and Mining.

Sevin Rosen Funds has a clear investment focus with a minimum and maximum investment size of $44,380,000, indicating a preference for significant, potentially transformative funding rounds in companies that they believe have high growth potential.

According to their website, the current active funds managed by Sevin Rosen are fully invested. This implies that any new investments will be restricted to the existing companies within their portfolio.

The team at Sevin Rosen consists of experienced individuals including Jon Bayless, Steve Domenik, Steve Dow, John Jaggers, Dave McLean, Jackie Kimzey, John Oxaal, Charles Phipps, Al Schuele, Nick Sturiale, and Alan Buehler. While they no longer participate in new funding rounds for emerging companies, their existing portfolio reflects their broad investment thesis and demonstrates their commitment to fostering innovative strategies across a plethora of cutting-edge industry sectors.